Virios Therapeutics Announces Pricing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study

Virios Therapeutics, Inc. announced the pricing of its previously announced public offering of 8,500,000 shares of its common stock at a public offering price of $0.20 per share.